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The stimulation of postprandial K+ clearance involves aldosterone-independent and -
dependent mechanisms. In this context, SGK1, an ubiquitously expressed kinase, is one of the 
primary aldosterone induced proteins in the aldosterone sensitive distal nephron (ASDN). 
Germline inactivation of SGK1 suggests that this kinase is fundamental for K+ excretion under 
conditions of K+ load, but the specific role of renal SGK1 remains elusive. To avoid 
compensatory mechanisms that may occur during nephrogenesis, we employed inducible, 
nephron-specific Sgk1Pax8/LC1 mice to assess the role of renal-tubular SGK1 in K+ regulation. 
Under standard diet, these animals exhibited normal K+ handling. When challenged by a high 
K+ diet (HKD), they developed severe hyperkalemia, accompanied by a defect in K+ excretion. 
Molecular analysis revealed reduced NEDD4-2 phosphorylation and total expression. γENaC 
expression and α/γENaC proteolytic processing were also decreased in the mutant mice. 
Moreover, WNK1, which displayed in control mice punctuate staining in the DCT and diffuse 
distribution in the CNT/CCD, was diffused in the DCT and less expressed in the CNT/CD of 
SgkPax8/LC1 mice. Moreover, SPAK phosphorylation, and NCC phosphorylation/apical 
localization were reduced in the mutant. Consistent with the altered WNK1 expression, 
increased ROMK apical localization was observed. In conclusion, our data suggest that renal-
tubular SGK1 is important in the regulation of K+ excretion via the control of NEDD4-2, WNK1 
and ENaC.  
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INTRODUCTION 
Maintenance of plasma potassium (K+) level within normal physiological range (3.5 to 
5.0 mM) is crucial for proper function of excitable cells (e.g., neurons, skeletal and cardiac 
myocytes) and represents a significant homeostatic challenge that is mediated by the tight 
coordination of K+ excretion via the kidney (and to a lesser extent colon), and K+ storage 
occurring mainly in skeletal muscle (67). It is well accepted that control of K+ balance by the 
kidney involves both aldosterone-dependent and -independent mechanisms (55, 56, 64). Renal 
K+ secretion takes place essentially in the so-called aldosterone sensitive distal nephron 
(ASDN) as defined by Loffing et al. (35). One of the most prominent proteins stimulated by 
aldosterone in the ASDN is the otherwise ubiquitously expressed serum- and glucocorticoid-
induced kinase 1 (SGK1) (28, 34). Studies performed in cellular and animal models suggest 
that SGK1 controls renal Na+ reabsorption through regulation of the epithelial Na+ channel 
ENaC and Na+,Cl--cotransporter NCC (3, 10, 17-19, 37, 65). This involves phosphorylation of 
S222, S246 and S328 residues of the ubiquitin-protein ligase NEDD4-2 (5, 17, 52), known to 
ubiquitylate and negatively regulate ENaC and NCC (1, 3, 22, 26, 45, 51). On the other hand, 
it has also been suggested that SGK1 acts via phosphorylation of WNK kinases (12, 44, 48). 
Several in vitro and in vivo reports confer to SGK1 a positive role in the regulation of 
K+ secretion. In heterologous expression systems SGK1 is able to stimulate the K+-channel 
ROMK (KCNJ1) cell surface expression (38, 66). Huang et al. (23) reported that mice 
harboring constitutive gene inactivation of Sgk1 (Sgk1-/-) exhibited a defect in acute K+ 
excretion after 30-60 min of intravenous K+ load. At 6 days of high K+ diet (HKD), Sgk1-/- mice 
developed hyperkalemia but excreted K+ similarly to control mice (23). Surprisingly, ROMK 
membrane expression was enhanced in Sgk1 -/- mice (23). The ubiquitous expression of SGK1 
together with the involvement of the colon, the skeletal muscle and the liver in K+ homeostasis, 
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leave the possibility that the impaired ability of Sgk1-/- mice to handle K+ load was due to renal 
and extra-renal SGK1 (6, 29).  
  
To decipher the specific role of renal-tubular SGK1 in K+ homeostasis, we took 
advantage of the previously described inducible, nephron specific Sgk1Pax8/LC1 model (18). 
These mice showed a Na+ losing phenotype when Na+ supply was restricted, which correlated 
with decreased NCC and ENaC protein levels, and reduced NEDD4-2 phosphorylation (18). 
Here, we show that even though SGK1 is expressed in several organs involved in K+ 
homeostasis, the action of renal-tubular SGK1 is crucial for proper renal K+ excretion and is 
mediated mainly by ENaC. Our data suggest that NEDD4-2 and WNK1 are key players in 
SGK1-mediated K+ homeostasis.  
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MATERIAL AND METHODS 
Induction of renal-tubule specific SGK1 mutant mice and the verification of the renal 
tubular specificity. Inducible, renal-tubule specific SGK1flox/flox/Pax8-rTA/LC1 KO 
(SGK1Pax8/LC1) or homozygous littermate controls Sgk1Pax8 or Sgk1LC1 mice were generated as 
previously described (18). Mice were housed in a temperature-controlled facility (19–22°C) 
with a 12:12-h light-dark cycle. To induce gene deletion, 21 to 24 day old mice were treated 
with doxycycline (2 mg/ml in 2% sucrose in drinking water) for 12 days. Male mice were used 
in the study after 1 to 3 weeks following doxycycline treatment. Genotype was identified by 
PCR performed on ear biopsies as described previously (18). Experimental protocols were 
designed with respect to the Swiss Animal Welfare Act and approved by the veterinary 
administration of the Canton de Vaud, Switzerland, authorization number is 2590. 
 
Dietary manipulation. Control (Sgk1Pax8 or Sgk1LC1) and Sgk1Pax8/LC1 doxycycline 
treated mice were fed a standard (0.3% K+; Sniff) or high-K+ diet (HKD) (5% K+, K+3-citrate 
was used as K+ supplement; Sniff) for the periods indicated in the related results.  
 
Plasma and organs collection. Mice were anesthetized by Ketamine/Xylazine 
intraperitoneal injection; blood was collected by exsanguination from the retro-orbital plexus 
in SARSTEDT heparin contained micro tubes and plasma was separated according to 
manufacturer's instructions. Mice were then humanely euthanized by cervical dislocation.  
 
Metabolic cages, urine and plasma analysis. After 2 days of adaptation in metabolic 
cages (Indulab, Cat. #3600M021), data related to bodyweight, food and water intake were 
registered and 24h urine samples were collected as described previously (18). Urine analysis 
(Na+, K+, Ca2+, Mg2+, PO43-, Creatinine, Urea) was performed by the Laboratory of Clinical 
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Chemistry at the Lausanne Hospital (CHUV) using a Modular Analytics System (Roche 
Diagnostics). Plasma Na+ and K+ levels were measured with a flame photometer (Cole-Palmer 
Instrument). Plasma aldosterone measurement was performed at the Service of Nephrology of 
the CHUV using the radioimmunoassay kit ALDOSTERONE-RIACT according to the 
manufacturer's instructions. 
 
Protein lysates preparation and immunoblotting. Frozen tissues were homogenized 
using buffer containing TrisHCl 50mM, pH7.5, EDTA 1mM, EGTA 1mM, Sucrose 0.27M, 
NaF 50mM, Na-pyrophosphate 5mM in addition to protease inhibitors purchased from ROCHE 
(Complete Cat. #11836145001). Protein homogenates were then centrifuged at 10’000g for 10 
min at 4°C, supernatant was collected and protein concentration was measured using the 
BradFord method (Uptima, Cat #UPF86420). For ROMK detection, an additional 
ultracentrifugation step at 100’000g for 1h was performed for membrane enrichment. 
Immunoblots were carried out and proteins quantified as previously described (45). 
 
Antibodies. Anti-NCC antibodies (43, 53). pT233SPAK (43); Total SPAK (Millipore 
#072271); Anti αENaC (53); anti β and γ (63); anti NEDD4-2 (26), anti pS222NEDD4-2 (18); 
anti-S328NEDD4-2 (20); anti pS256SGK1 (Santa Cruz, # SC-16744); anti GAPDH (Millipore, 
#MAB374); anti actin (Sigma-Aldrich, #A-5316); anti WNK1 (Exon 12; (47)); anti 
p382WNK1/WNK4 (Pan-pWNK (55)).  
 
Generation and characterization of ROMK antibody. Anti-ROMK antibodies are 
directed against a sequence of 49 residues (342-391) of rat ROMK protein 
(NFGKTVEVETPHCAMCLYNEKDARARMKRGYDNPNFVLSEVDETDDTQM). Guinea 
pigs were immunized by GST fusion proteins containing the ROMK peptide. Antibodies were 
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generated at Cocalico Biologicals. Inc. (Reamstown, PA, USA). Sera of the immunized animals 
were collected and affinity-purified using the Maltose Binding Fusion Protein (MBP) system. 
The specificity of the antibodies was validated by Western blotting of lysates of HEK293 cell 
transfected with a plasmid encoding ROMK and kidneys from WT and ROMK knockout mice 
(Kcnj1 KO) (36) kept under HKD for 5 days to enhance ROMK protein expression (Fig. 5).  
 
Immunohistochemistry. Mice were anesthetized by Ketamine/Xylazine i.p. injection. 
Cardiac perfusions with PBS followed by PFA 4% were performed. Before freezing, fixed 
kidneys were kept in 30% sucrose in PBS solution at 4°C overnight. Immunostaining was 
performed on 5µ cryosections using the primary antibodies listed in the antibody section below. 
Alexa Fluor-488 conjugated goat anti-rabbit (Life-Technologies, Cat #A-11008,), Alexa Fluor-
546 conjugated to goat anti-guinea pig (Thermo Fisher Scientific, Cat #A11074) or Alexa 
Fluor-546 conjugated to donkey anti-sheep (Thermo Fisher Scientific; Cat #A21098) were 
used. Images in the Figures are representatives of data obtained from 3 control and 2 
Sgk1Pax8/LC1 mice. 
  
RNA extraction and TaqMan® Gene Expression Assays. Total RNA was purified from 
total kidneys using TRIzol (Ambion) and precipitated with isopropanol. cDNA was synthetized 
from 2–5 μg of total RNA using SuperScript II reverse transcriptase (Life-Technologies) and 
random hexamers (Promega). TaqMan Gene Expression Assays (Life Technologies) were used 
to analyze gene expression.  Primers/probes were: Nedd4l (NEDD4-2; ThermoFisher Scientific 
Mm00459584_m1), Sgk1 (Mm00441380_m1), Scann1a (αENaC; Mm00803386_m1), 
Scann1b (βENaC; Mm00441215_m1), Scann1c (γENaC; Mm00441228_m1), Renin-1 
(Mm02342889_g1); Gapdh (Mm99999915_g1).  
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Statistical analysis. The significance of the metabolic parameters of the experimental groups 
under different diets were analyzed using Two-way ANOVA followed by Bonferroni multiple 
comparisons tests. Values were considered significant when α < 0.05. When involving only one 
factor, the data were statistically analyzed using an unpaired Student's t test. Values were 
considered significant when p ≤ 0.05. Data are represented as means ± standard error of the 
mean (sem). 
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RESULTS 
Sgk1Pax8/LC1 mice display suppression of SGK1 in the kidney, but not in the liver.  
The present model, Sgk1Pax8/LC1, was described previously; recombination of genomic 
DNA was not only reported for the kidney, but also the liver (18), consistent with Pax8 
promotor activity as reported previously (57). We therefore analyzed Sgk1 mRNA and SGK1 
protein expression in the liver and compared it to the kidney (Fig. 1). Whereas there was 
recombination as seen previously in both organs (Fig. 1A), mRNA and protein levels of SGK1 
(using an anti pT256-SGK1 antibody) were not affected in the liver, whereas they were strongly 
reduced in the kidney (Fig. 1B-D). We therefore conclude that SGK1 is primarily deleted in the 
nephron; we cannot exclude, however, that there is some suppression in a minor subpopulation 
of liver cells. 
Severe hyperkalemia correlating with diminished K+ excretion in Sgk1Pax8/LC1 
mice under challenging conditions. 
  To understand the involvement of renal-tubular SGK1 in K+ homeostasis, we assessed 
metabolic parameters of control and inducible Sgk1Pax8/LC1 mice under normal (ND; containing 
0.3 % K+) and high K+ diet (HKD, 5% of K+; K+3-citrate) after 48 hours. We sacrificed the 
animals at the end of the daylight period, in order to have maximal aldosterone levels and assure 
highest difference between Sgk1Pax8/LC1 and controls. No significant differences in urine and 
plasma electrolytes were observed between the genotypes under ND (Fig. 2 and Table 1). After 
2 days of HKD, Sgk1Pax8/LC1 mice developed severe hyperkalemia and mild hyponatremia (Fig. 
2A, B), accompanied with elevated aldosterone levels (Fig. 2C), but no change of mRNA levels 
of renin 1 in the kidney (Fig. 2F). K+ excretion was enhanced upon the consumption of HKD 
in both genotypes, but this increase was less important in Sgk1Pax8/LC1mutants (Fig. 2D). No 
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significant difference in Na+ excretion was observed between the two groups (Fig. 2E). After 5 
days of HKD consumption, the mutant mice were capable to increase their urinary K+ secretion 
to levels similar to the one observed in control mice, as no significant difference in K+ excretion 
was observed between control (1664.2 +/- 71 mmol/day) and mutant (1319.5 +/- 124 mmol/day) 
mice after 5 days of HKD intake, suggesting that they come back into balance. 
 Taken together, these data suggest that basal levels of K+ excretion do not require the 
renal-tubular SGK1, whereas the kinase appears to be crucial for the adjustment of K+ 
elimination after a high K+ load for 48 hours. Moreover, the finding that Sgk1Pax8/LC1 show 
higher circulating aldosterone but no change in kidney renin 1 mRNA levels under basal and 
HKD conditions, suggests that the increased aldosterone levels are primarily a compensation 
for disturbed K+ regulation. 
 
Aberrant ENaC cleavage, expression and membrane localization in Sgk1Pax8/LC1 
mice under HKD 
It was previously described that Sgk1-/- mice develop hyperkalemia when subjected to 
HKD (23). Electrophysiological measurements in isolated perfused cortical collecting ducts 
(CCDs) from Sgk1-/- animals showed lower absolute and amiloride-sensitive transepithelial 
potential differences, suggesting a defect in Na+,K+-ATPase and/or ENaC (23). We therefore 
assessed ENaC expression and localization including full-length and proteolytically processed 
forms, representing ENaC maturation and activation (24, 46). Under ND, ENaC showed similar 
protein expression and patterns in Sgk1Pax8/LC1 versus control mice (data now shown). However, 
after 2 days of HKD, the cleavage product of αENaC, and both full-length and cleaved γENaC 
were decreased with no change in βENaC (Fig. 3A,B); this difference was accompanied by a 
decrease in αENaC apical localization and a reduction in intracellular and apical γENaC 
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expression (Fig. 3C). mRNA levels of the ENaC subunits did not change (not shown). These 
observations suggest that under HKD, the deficiency of renal epithelial SGK1 causes a defect 
in ENaC regulation.   
 
Sgk1Pax8/LC1 mice display alterations in NEDD4-2/WNK1pathway under HKD 
As outlined above, it is well documented that SGK1 phosphorylates NEDD4-2, thereby 
interfering with NEDD4-2 dependent inhibition of ENaC and NCC (3, 5, 8, 17, 52). Because 
membrane localization of α- and γENaC was altered in Sgk1Pax8/LC1 mice under HKD, we 
evaluated the phosphorylation status of NEDD4-2 and observed a reduction in S222 and S328 
phosphorylation in Sgk1Pax8/LC1 mice (Fig. 4A,B). Interestingly, total NEDD4-2 expression was 
also decreased (Fig. 4A-C) without any change in mRNA levels (not shown). No alteration in 
NEDD4-2 phosphorylation or protein levels was observed in the Sgk1Pax8/LC1 mice under normal 
diet (not shown). We have recently demonstrated that WNK1 is ubiquitylated and negatively 
controlled by NEDD4-2. Proteins levels of the “long” kinase active isoform (L-WNK1) protein 
levels were increased in NeddlPax8/LC1 animals kept under high Na+ diet and decreased in 
Sgk1Pax8/LC1 mice under low Na+ diet (47). Under the present conditions (48h of HKD), Western 
blot analysis did not reveal a significant decrease in WNK1 in the Sgk1Pax8/LC1 mice (Fig. 4A,B), 
but we observed important changes by immunofluorescence analysis. The stainings in control 
mice showed that in the DCT (co-localization with NCC), WNK1 exhibited a punctate pattern 
(Fig. 4D). Such localization profile had been previously described for WNK4 (55). On the other 
hand, in the CNT/CD (co-localization with AQP2) of these mice, WNK1 was homogenously 
diffused within the cells (Fig. 4E). This segment-specific pattern of WNK1 may be related to 
differences in the signaling pathway associated to WNK1 in each segment. In contrast, in the 
Sgk1Pax8/LC1 mice, WNK1 in the DCT displayed a diffuse localization (Fig. 4D). In addition, its 
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expression was reduced in the CNT/CD compared to control littermates (Fig. 4E). These 
deregulations were related to a decrease in WNK activity in both DCT and CNT/CD of mutant 
compared to control mice as evidenced by the reduced staining with a p382WNK1/WNK4 
(Pan-pWNK) antibody, an indicator of WNK1/WNK4 activity (Fig. 5). These data suggest that 
SGK1 controls NEDD4-2 phosphorylation also under HK conditions (as was the case with a 
low Na+ diet (18)), and influences the subcellular localization/expression and activity of 
WNK1.  
 
Sgk1Pax8/LC1 KO mice show increased ROMK expression  
SGK1 had been suggested to be a positive regulator of ROMK (32, 38, 44, 66, 68, 69). 
Surprisingly, however, in the hyperkalemic Sgk1-/- KO mice, apical localization of ROMK was 
increased (23). One possible explanation for this apparent contradiction might be compensatory 
mechanisms taking place during nephrogenesis. We generated a novel anti-ROMK antibody in 
guinea pigs as described in Material and Methods, and validated the antibody by Western 
blotting (Fig. 6A,B). The antibody recognized transfected ROMK in HEK293 cells and in total 
kidney membrane extracts, whereas the corresponding bands were not visible in non-transfected 
cells or in kidneys from ROMK KO mice (Kcnj1 KO mice). We then analyzed ROMK in 
Sgk1Pax8/LC1 kidneys from mice kept under HKD and found also in this model a slight increase 
in the fully-glycosylated form of ROMK in Sgk1Pax8/LC1 animals (Fig. 6C, D). 
Immunofluorescence analysis further revealed that ROMK protein abundance and membrane 
expression were enhanced both in the DCT and CNT/CD of Sgk1Pax8/LC1 animals as indicate the 
co-localization images of ROMK with either NCC or αENaC (Fig. 6E, F). This suggests that 
the hyperkalemia triggered by renal SGK1 deletion is independent of ROMK. 
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NCC and SPAK phosphorylation is altered in Sgk1Pax8/LC1 mice  
NCC dephosphorylation under K+ load has been described in several reports (42, 53-55, 
58). To analyze the response of NCC to the observed hyperkalemia in Sgk1Pax8/LC1 mice, we 
analyzed NCC phosphorylation and expression both under ND and after 2 days of HKD. We 
found that under ND, NCC phosphorylation and expression were similar in Sgk1Pax8/LC1 and 
control mice (not shown). Under HKD, NCC phosphorylation levels were much weaker in the 
mutant mice and no difference in total NCC expression was observed (Fig. 7A-C). In addition, 
immunofluorescence analysis of kidney sections revealed that NCC was less localized to the 
apical membrane in the KO mice (Fig. 7C). We then asked if this weak NCC phosphorylation 
correlated with changes in SPAK phosphorylation, a kinase known to phosphorylate and 
activate NCC (43). SPAK is phosphorylated by WNK kinases on threonine (T233) in the T-
loop of the kinase domain that is crucial for SPAK activation (2, 61). Our IF analyses revealed 
that similarly to WNK1, total SPAK exhibited a punctuate pattern in the distal convoluted 
tubule (DCT) of control animals, which was less pronounced in Sgk1Pax8/LC1 mice (Fig. 7D). 
Phosphorylation at T233 was reduced in the DCT as compared to control animals consistent 
with the reduced NCC phosphorylation (Fig. 7E). Together, these data show that under HKD, 
NCC phosphorylation and membrane localization are both diminished in the Sgk1Pax8/LC1 mice, 
coinciding with a reduction in SPAK activation.  
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DISCUSSION 
This study shows that mice with inducible deletion of renal-tubular SGK1 exhibit 
reduced K+ excretion as compared to control animals, leading to severe hyperkalemia when 
subjected to HKD. The reduced K+ excretion is correlated to altered NEDD4-2 and WNK1 in 
addition to reduced apical membrane expression of ENaC. Our observations confirm partly the 
previous report by Huang et al. demonstrating that total Sgk1-/- mice display normal K+ handling 
when fed standard diet, but develop hyperkalemia, although without a difference in K+ 
excretion, when challenged by HKD (23). We also observed elevated aldosterone levels (but 
no difference in renin 1 mRNA expression in the kidney) in Sgk1Pax8/LC1 mice both under 
standard and K+ rich diets similarly to Sgk1-/- mice (23). Given the similar K+ content in the 
HKD used in both studies (5% K+ ), the lower K+ excretion observed under chronic HKD in 
Sgk1Pax8/LC1 but not Sgk1-/- mice suggests that renal-tubular SGK1 plays a critical role in the 
regulation of K+ excretion under HKD and its role may be attenuated by compensatory 
mechanisms triggered during nephrogenesis in Sgk1-/- mice. Extra-renal SGK1 had been shown 
previously to play a role in K+ homeostasis as suggested by experiments performed in Sgk1-/- 
animals demonstrating that hepatic SGK1 regulates kalemia via its role in insulin-stimulated 
K+ uptake (6). In our mice, we found no evidence for suppression of SGK1 in the liver; although 
we cannot exclude suppression of SGK1 in a subpopulation of liver cells, we consider it as 
unlikely that hepatic SGK1 plays a major role in this model. Finally, we cannot exclude that 
strain background differences may contribute to the alterations as well. 
 
Our molecular analyses suggest that the effect of SGK1 on K+ balance is mediated at 
least in part by the positive regulation of ENaC, implicating phosphorylation and consequent 
interference with NEDD4-2 action (5, 17-19, 21, 25, 31, 52). After 2 days of HKD, NEDD-2 
phosphorylation and total expression were reduced in Sgk1Pax8/LC1 with no alteration of its 
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mRNA level. Similar observations were made in Sgk1Pax8/LC1 animals under low salt diet 
showing reduced NEDD4-2 phosphorylation on both S222 and S328 sites (18). However, the 
decrease in NEDD4-2 total expression found here might be due to the hyperkalemia and/or to 
increased aldosterone levels. Indeed, van der Lubbe et al. had shown that NEDD4-2 expression 
was decreased in rats fed with HKD (59). Moreover, Loffing-Cueni et al. had described that 
low Na+ diet caused reduction in NEDD4-2 expression, and provided evidence that it was 
aldosterone dependent inhibition of NEDD4-2 levels (33). Taken together, this suggests that 
aldosterone inhibits NEDD4-2 action via 1) SGK1-dependent phosphorylation (likely a rapid 
mechanism of regulation) and 2) lowering its expression by an uncharacterized post-
transcriptional mechanism (slow or late mode).  NEDD4-2 phosphorylation at S328 interferes 
with regulation of ENaC (17, 52). Consistent with this, we observed under HKD lower 
expression of γENaC, as well as decreased cleavage of α- and γENaC, features that had been 
associated with increased ubiquitylation of ENaC (24, 27, 49, 50). Our findings are in line with 
previous reports showing the decrease in γENaC cleavage in Sgk1-/- mice treated by aldosterone 
for 7 days (19). These Sgk1-/- mice exhibited a Na+ losing phenotype under low salt diet, but 
intriguingly an increase in amiloride-sensitive Na+ currents, as measured by whole-cell patch-
clamping in the CCD. In contrast, low amiloride-sensitive transepithelial potential differences 
(a marker for ENaC activity) in isolated CCDs from Sgk1-/- mice under HKD were reported by 
Huang et al. (23). Similarly to the Sgk1-/- mice, Sgk1Pax8/LC1 did not exhibit Na+ loss compared 
to control mice when fed HKD despite the observed decrease in α and γENaC inactivation and 
NCC. One possible explanation is an increase in Na+ reabsorption in the proximal tubules as 
previously reported in Sgk1-/- under low salt diet (65). Interestingly, transgenic mice with 
specific deletion of αENaC in renal-tubules (39) or only in the CNT (13, 41) exhibit 
hyperkalemia and decreased K+ excretion. In view of what precedes, we consider it as very 
likely that the low ENaC cleavage and membrane localization in the Sgk1Pax8/LC1 mice account 
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at least in part for the observed decrease in K+ excretion, by limiting the electrogenic driving 
force for K+ secretion.  
 
We also observed that Sgk1Pax8/LC1 mice exhibited decreased phosphorylation and apical 
localization of NCC after 2 days of HKD. Vallon et al., had shown that Sgk1-/- mice fed with 
HKD (5% K+) for 7 days exhibit decreased NCC phosphorylation and total protein expression 
(58). The longer exposure to HKD may explain this more severe NCC alteration observed by 
these authors. Our data suggest that the decrease in NCC apical localization in Sgk1Pax8/LC1 mice 
is likely an effect of reduced NEDD4-2 phosphorylation leading to increased activity towards 
NCC (3). The deregulation of NCC in our model was accompanied by reduced phosphorylation 
of WNK1/4 S382 and SPAK T233. Recently, Roy et al. have reported that L-WNK1 kinase, 
known to stimulate NCC via SPAK/OSR1 kinase, is a target of NEDD4-2 (47) and the 
expression of L-WNK1 was reduced in SgkPax8/LC1 mice fed with a low Na+ diet. Though we 
did not detect a statistically significant reduction in WNK1 protein expression in SgkPax8/LC1 
mice under our conditions, we did observe a striking alteration in the WNK1 localization pattern 
in both the DCT and the CNT/CD. Taken together with the observation that WNK1 
phosphorylation was reduced under HKD conditions, our data suggest that SGK1 regulates 
NCC phosphorylation via WNK kinases, and the NEDD4-2/WNK1/SPAK pathway 
participates in this process. Another mechanism for NCC regulation was proposed by Rozansky 
& collaborators, who suggested that phosphorylation of WNK4 by SGK1 on S1196 inhibits 
WNK4 dependent downregulation of NCC (48). However, regulation of NCC by WNK4 is 
complex, and can be both inhibitory and stimulatory, depending on the physiological context 
(9). To our knowledge, no antibodies against this WNK4 phosphorylation site are currently 
available (32, 44), hence we were not able to test this possibility in our model. It was also 
reported that intracellular Cl- is able to inhibit WNK kinases (4, 40) and evidence was presented 
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that low plasma K+ leads to lower intracellular [Cl-] and stimulation of WNK kinase activity 
(i.e. WNK1, WNK3 and WNK4 (7, 54, 55)). Consequently, hyperkalemia may cause an 
increase in intracellular [Cl-] and inhibition of the WNK kinases. Taken together, the 
deregulation in NCC apical localization and phosphorylation in Sgk1Pax8/LC1 mice under HKD 
may be due to decreased NEDD4-2 phosphorylation and reduced L-WNK1 expression and 
activity, exacerbated by hyperkalemia. Moreover, it is important to note that the reduced 
phosphorylation levels of NCC is likely a secondary effect of the hyperkalemia and not the 
cause of it. 
 
The regulation of ROMK by SGK1 is still under debate. Several in vitro reports suggest 
a positive regulation of the channel by SGK1 (11, 38, 66). However, in vivo studies do not 
confirm this hypothesis (23, 56). Our data show that ROMK protein levels and membrane 
localization are increased in Sgk1Pax8/LC1 mice under HKD, indicating that a deregulation of 
ROMK cannot account for the decrease in K+ excretion in Sgk1Pax8/LC1 animals. This is in 
agreement with the observation made in Sgk1-/- and aldosterone synthase-KO mice, which 
exhibit hyperkalemia together with increased ROMK membrane expression when fed with 
HKD (23, 56). Importantly, in vitro and in vivo evidences suggest that L-WNK1 inhibits ROMK 
by stimulating its endocytosis (14, 30, 60, 62). Consequently, the increased ROMK levels are 
compatible with the observed decrease of WNK1 expression and activity in our mouse model. 
We note that the findings regarding ROMK regulation in our mice indicate that the mechanisms 
of K+ excretion, affected by SGK1, may also involve other channels/transporters such as the 
BK (15), Kir4.1 (Kcnj10) (70) channels or the H+,K+-ATPase (16).  This will be addressed by 
future studies.   
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Taken together, the renal-tubular SGK1 plays a crucial role in K+ homeostasis via the 
regulation of NEDD4-2 mediated ENaC inhibition. Sgk1Pax8/LC1 mice exhibit an alteration of 
WNK1 puncta in the DCT and a decrease of WNK1 staining in the CNT/CD. This is correlated 
with decreased SPAK/NCC phosphorylation and increased ROMK expression/apical 
localization in the DCT/CNT/CD.  
   
19 
 
ACKNOWLEDGMENTS 
We thank Drs. Bernard Rossier, Laurent Schild, and the members of the Staub lab for 
comments and critically reading the manuscript. We also thank Andrée Tedjani, Sebastien 
Desarzens, and Jérémy Vidal for technical help, and Alessia Spirli for help with the statistical 
analysis. This work was supported by the Swiss National Science Foundation Grant # 
310030_159735 (to OS) and 310030_143929/1 (to JL) the National Centre of Competence in 
Research “Swiss Kidney.ch” (to OS and JL), networking support by the COST Action 
ADMIRE BM1301 (to OS and JL), Novartis Foundation for medical-biological research (to 
OS), NIH grant R01DK098145 (to ARS). LAQ was supported by a fellowship of the Marie 
Curie Co-funding IKPP (International Fellowship Program on Integrative Kidney Physiology 
and Pathophysiology).  
  
20 
 
REFERENCES 
1. Abriel H, Loffing J, Rebhun JF, Pratt JH, Schild L, Horisberger JD, Rotin D, and Staub 
O. Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle's syndrome. J Clin Invest 103: 
667-673, 1999. 
2. Alessi DR, Zhang J, Khanna A, Hochdorfer T, Shang Y, and Kahle KT. The WNK-
SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters. Sci Signal 7: re3, 2014. 
3. Arroyo JP, Lagnaz D, Ronzaud C, Vazquez N, Ko BS, Moddes L, Ruffieux-Daidie D, 
Hausel P, Koesters R, Yang B, Stokes JB, Hoover RS, Gamba G, and Staub O. Nedd4-2 Modulates 
Renal Na+-Cl- Cotransporter via the Aldosterone-SGK1-Nedd4-2 Pathway. J Am Soc Nephrol 22: 1707-
1719, 2011. 
4. Bazua-Valenti S, Chavez-Canales M, Rojas-Vega L, Gonzalez-Rodriguez X, Vazquez N, 
Rodriguez-Gama A, Argaiz ER, Melo Z, Plata C, Ellison DH, Garcia-Valdes J, Hadchouel J, and 
Gamba G. The Effect of WNK4 on the Na+-Cl- Cotransporter Is Modulated by Intracellular Chloride. 
J Am Soc Nephrol 26: 1781-1786, 2015. 
5. Bhalla V, Daidie D, Li H, Pao AC, LaGrange LP, Wang J, Vandewalle A, Stockand JD, 
Staub O, and Pearce D. Serum- and glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural 
precursor cell-expressed, developmentally down-regulated protein 4-2 by inducing interaction with 14-
3-3. Mol Endocrinol 19: 3073-3084, 2005. 
6. Boini KM, Graf D, Kuhl D, Haussinger D, and Lang F. SGK1 dependence of insulin induced 
hypokalemia. Pflugers Arch 457: 955-961, 2009. 
7. Castaneda-Bueno M, Cervantes-Perez LG, Rojas-Vega L, Arroyo-Garza I, Vazquez N, 
Moreno E, and Gamba G. Modulation of NCC activity by low and high K(+) intake: insights into the 
signaling pathways involved. Am J Physiol Renal Physiol 306: F1507-1519, 2014. 
8. Chandran S, Li H, Dong W, Krasinska K, Adams C, Alexandrova L, Chien A, Hallows 
KR, and Bhalla V. Neural precursor cell-expressed developmentally down-regulated protein 4-2 
(Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) 
phosphorylation sites. J Biol Chem 286: 37830-37840, 2011. 
9. Chavez-Canales M, Zhang C, Soukaseum C, Moreno E, Pacheco-Alvarez D, Vidal-Petiot 
E, Castaneda-Bueno M, Vazquez N, Rojas-Vega L, Meermeier NP, Rogers S, Jeunemaitre X, 
Yang CL, Ellison DH, Gamba G, and Hadchouel J. WNK-SPAK-NCC cascade revisited: WNK1 
stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4. 
Hypertension 64: 1047-1053, 2014. 
10. Chen S, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, 
Verrey F, and Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc 
Natl Acad Sci U S A 96: 2514-2519, 1999. 
11. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, 
Verrey F, and Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc 
Natl Acad Sci U S A 96: 2514-2519, 1999. 
12. Cheng CJ, and Huang CL. Activation of PI3-kinase stimulates endocytosis of ROMK via 
Akt1/SGK1-dependent phosphorylation of WNK1. J Am Soc Nephrol 22: 460-471, 2011. 
13. Christensen BM, Perrier R, Wang Q, Zuber AM, Maillard M, Mordasini D, Malsure S, 
Ronzaud C, Stehle JC, Rossier BC, and Hummler E. Sodium and potassium balance depends on 
alphaENaC expression in connecting tubule. J Am Soc Nephrol 21: 1942-1951, 2010. 
14. Cope G, Murthy M, Golbang AP, Hamad A, Liu CH, Cuthbert AW, and O'Shaughnessy 
KM. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. J Am 
Soc Nephrol 17: 1867-1874, 2006. 
15. Cornelius RJ, Wen D, Li H, Yuan Y, Wang-France J, Warner PC, and Sansom SC. Low 
Na, high K diet and the role of aldosterone in BK-mediated K excretion. PLoS One 10: e0115515, 2015. 
16. Crambert G. H-K-ATPase type 2: relevance for renal physiology and beyond. Am J Physiol 
Renal Physiol 306: F693-700, 2014. 
17. Debonneville C, Flores SY, Kamynina E, Plant PJ, Tauxe C, Thomas MA, Munster C, 
Chraibi A, Pratt JH, Horisberger JD, Pearce D, Loffing J, and Staub O. Phosphorylation of Nedd4-
2 by Sgk1 regulates epithelial Na(+) channel cell surface expression. EMBO J 20: 7052-7059, 2001. 
21 
 
18. Faresse N, Lagnaz D, Debonneville A, Ismailji A, Maillard M, Fejes-Toth G, Naray-Fejes-
Toth A, and Staub O. Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype. 
Am J Physiol Renal Physiol 302: F977-985, 2012. 
19. Fejes-Toth G, Frindt G, Naray-Fejes-Toth A, and Palmer LG. Epithelial Na+ channel 
activation and processing in mice lacking SGK1. Am J Physiol Renal Physiol 294: F1298-1305, 2008. 
20. Flores SY, Loffing-Cueni D, Kamynina E, Daidie D, Gerbex C, Chabanel S, Dudler J, 
Loffing J, and Staub O. Aldosterone-Induced Serum and Glucocorticoid-Induced Kinase 1 Expression 
Is Accompanied by Nedd4-2 Phosphorylation and Increased Na+ Transport in Cortical Collecting Duct 
Cells. J Am Soc Nephrol 16: 2279-2287, 2005. 
21. Gleason CE, Frindt G, Cheng CJ, Ng M, Kidwai A, Rashmi P, Lang F, Baum M, Palmer 
LG, and Pearce D. mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity. J Clin 
Invest 125: 117-128, 2015. 
22. Harvey KF, Dinudom A, Cook DI, and Kumar S. The Nedd4-like Protein KIAA0439 Is a 
Potential Regulator of the Epithelial Sodium Channel. J Biol Chem 276: 8597-8601, 2001. 
23. Huang DY, Wulff P, Volkl H, Loffing J, Richter K, Kuhl D, Lang F, and Vallon V. Impaired 
regulation of renal K+ elimination in the sgk1-knockout mouse. J Am Soc Nephrol 15: 885-891, 2004. 
24. Hughey RP, Mueller GM, Bruns JB, Kinlough CL, Poland PA, Harkleroad KL, Carattino 
MD, and Kleyman TR. Maturation of the epithelial Na+ channel involves proteolytic processing of the 
alpha- and gamma-subunits. J Biol Chem 278: 37073-37082, 2003. 
25. Ichimura T, Yamamura H, Sasamoto K, Tominaga Y, Taoka M, Kakiuchi K, Shinkawa 
T, Takahashi N, Shimada S, and Isobe T. 14-3-3 proteins modulate the expression of epithelial Na+ 
channels by phosphorylation-dependent interaction with Nedd4-2 ubiquitin ligase. J Biol Chem 280: 
13187-13194, 2005. 
26. Kamynina E, Debonneville C, Bens M, Vandewalle A, and Staub O. A novel mouse Nedd4 
protein suppresses the activity of the epithelial Na+ channel. FASEB J 15: 204-214, 2001. 
27. Knight KK, Olson DR, Zhou R, and Snyder PM. Liddle's syndrome mutations increase Na+ 
transport through dual effects on epithelial Na+ channel surface expression and proteolytic cleavage. 
Proc Natl Acad Sci U S A 103: 2805-2808, 2006. 
28. Lang F, Stournaras C, and Alesutan I. Regulation of transport across cell membranes by the 
serum- and glucocorticoid-inducible kinase SGK1. Mol Membr Biol 31: 29-36, 2014. 
29. Lang F, and Vallon V. Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal 
and extrarenal potassium transport. Clin Exp Nephrol 16: 73-80, 2012. 
30. Lazrak A, Liu Z, and Huang CL. Antagonistic regulation of ROMK by long and kidney-
specific WNK1 isoforms. Proc Natl Acad Sci U S A 103: 1615-1620, 2006. 
31. Liang X, Peters KW, Butterworth MB, and Frizzell RA. 14-3-3 isoforms are induced by 
aldosterone and participate in its regulation of epithelial sodium channels. J Biol Chem 281: 16323-
16332, 2006. 
32. Lin DH, Yue P, Rinehart J, Sun P, Wang Z, Lifton R, and Wang WH. Protein phosphatase 
1 modulates the inhibitory effect of With-no-Lysine kinase 4 on ROMK channels. Am J Physiol Renal 
Physiol 303: F110-119, 2012. 
33. Loffing-Cueni D, Flores SY, Sauter D, Daidie D, Siegrist N, Meneton P, Staub O, and 
Loffing J. Dietary sodium intake regulates the ubiquitin-protein ligase nedd4-2 in the renal collecting 
system. J Am Soc Nephrol 17: 1264-1274, 2006. 
34. Loffing J, Flores SY, and Staub O. Sgk kinases and their role in epithelial transport. Annu Rev 
Physiol 68: 461-490, 2006. 
35. Loffing J, Zecevic M, Feraille E, B. K, Asher C, Rossier BC, Firestone GL, Pearce D, and 
Verrey F. Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting 
system: possible role of SGK. Am J Physiol Renal Physiol 280: F675-F682, 2001. 
36. Lu M, Wang T, Yan Q, Yang X, Dong K, Knepper MA, Wang W, Giebisch G, Shull GE, 
and Hebert SC. Absence of small conductance K+ channel (SK) activity in apical membranes of thick 
ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice. J Biol Chem 277: 
37881-37887, 2002. 
37. Naray-Fejes-Toth A, Canessa CM, Cleaveland ES, Aldrich G, and Fejes-Toth G. sgk is an 
aldosterone-induced kinase in the renal collecting duct. J Biol Chem 274: 16973-16978, 1999. 
22 
 
38. Palmada M, Embark HM, Yun C, Bohmer C, and Lang F. Molecular requirements for the 
regulation of the renal outer medullary K(+) channel ROMK1 by the serum- and glucocorticoid-
inducible kinase SGK1. Biochem Biophys Res Commun 311: 629-634, 2003. 
39. Perrier R, Boscardin E, Malsure S, Sergi C, Maillard MP, Loffing J, Loffing DC, Sorensen 
MV, Koesters R, Rossier BC, Frateschi S, and Hummler E. Severe Salt-Losing Syndrome and 
Hyperkalemia Induced by Adult Nephron-Specific Knockout of the Epithelial Sodium Channel alpha-
Subunit. J Am Soc Nephrol in press: 2016. 
40. Piala AT, Moon TM, Akella R, He H, Cobb MH, and Goldsmith EJ. Chloride Sensing by 
WNK1 Involves Inhibition of Autophosphorylation. Sci Signal 7: ra41, 2014. 
41. Poulsen SB, Praetorius J, Damkier HH, Miller L, Nelson RD, Hummler E, and 
Christensen BM. Reducing alphaENaC expression in the kidney connecting tubule induces 
pseudohypoaldosteronism type 1 symptoms during K+ loading. Am J Physiol Renal Physiol 310: F300-
310, 2016. 
42. Rengarajan S, Lee DH, Oh YT, Delpire E, Youn JH, and McDonough AA. Increasing 
plasma [K+] by intravenous potassium infusion reduces NCC phosphorylation and drives kaliuresis and 
natriuresis. Am J Physiol Renal Physiol 306: F1059-1068, 2014. 
43. Richardson C, Rafiqi FH, Karlsson HK, Moleleki N, Vandewalle A, Campbell DG, 
Morrice NA, and Alessi DR. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-
regulated kinases SPAK and OSR1. J Cell Sci 121: 675-684, 2008. 
44. Ring AM, Leng Q, Rinehart J, Wilson FH, Kahle KT, Hebert SC, and Lifton RP. An SGK1 
site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone 
signaling and K+ homeostasis. Proc Natl Acad Sci U S A 104: 4025-4029, 2007. 
45. Ronzaud C, Loffing-Cueni D, Hausel P, Debonneville A, Malsure SR, Fowler-Jaeger N, 
Boase NA, Perrier R, Maillard M, Yang B, Stokes JB, Koesters R, Kumar S, Hummler E, Loffing 
J, and Staub O. Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent 
hypertension. J Clin Invest 123: 657-665, 2013. 
46. Rossier BC, and Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine 
proteases. Annu Rev Physiol 71: 361-379, 2009. 
47. Roy A, Al-Qusairi L, Donnelly BF, Ronzaud C, Marciszyn AL, Gong F, Chang YP, 
Butterworth MB, Pastor-Soler NM, Hallows KR, Staub O, and Subramanya AR. Alternatively 
spliced proline-rich cassettes link WNK1 to aldosterone action. J Clin Invest 125: 3433-3448, 2015. 
48. Rozansky DJ, Cornwall T, Subramanya AR, Rogers S, Yang YF, David LL, Zhu X, Yang 
CL, and Ellison DH. Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter 
through an SGK1 and WNK4 signaling pathway. J Clin Invest 119: 2601-2612, 2009. 
49. Ruffieux-Daidie D, Poirot O, Boulkroun S, Verrey F, Kellenberger S, and Staub O. 
Deubiquitylation regulates activation and proteolytic cleavage of ENaC. J Am Soc Nephrol 19: 2170-
2180, 2008. 
50. Ruffieux-Daidie D, and Staub O. Intracellular Ubiquitylation of the Epithelial Na+ Channel 
Controls Extracellular Proteolytic Channel Activation via Conformational Change. J Biol Chem 286: 
2416-2424, 2011. 
51. Shi PP, Cao XR, Sweezer EM, Kinney TS, Williams NR, Husted RF, Nair R, Weiss RM, 
Williamson RA, Sigmund CD, Snyder PM, Staub O, Stokes JB, and Yang B. Salt-sensitive 
hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2. Am J Physiol 
Renal Physiol 295: F462-470, 2008. 
52. Snyder PM, Olson DR, and Thomas BC. Serum and Glucocorticoid-regulated Kinase 
Modulates Nedd4-2-mediated Inhibition of the Epithelial Na+ Channel. J Biol Chem 277: 5-8, 2002. 
53. Sorensen MV, Grossmann S, Roesinger M, Gresko N, Todkar AP, Barmettler G, Ziegler 
U, Odermatt A, Loffing-Cueni D, and Loffing J. Rapid dephosphorylation of the renal sodium 
chloride cotransporter in response to oral potassium intake in mice. Kidney Int 83: 811-824, 2013. 
54. Terker AS, Zhang C, Erspamer KJ, Gamba G, Yang CL, and Ellison DH. Unique chloride-
sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis. Kidney Int 
2015. 
55. Terker AS, Zhang C, McCormick JA, Lazelle RA, Meermeier NP, Siler DA, Park HJ, Fu 
Y, Cohen DM, Weinstein AM, Wang WH, Yang CL, and Ellison DH. Potassium modulates 
23 
 
electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab 
21: 39-50, 2015. 
56. Todkar A, Picard N, Loffing-Cueni D, Sorensen MV, Mihailova M, Nesterov V, 
Makhanova N, Korbmacher C, Wagner CA, and Loffing J. Mechanisms of renal control of 
potassium homeostasis in complete aldosterone deficiency. J Am Soc Nephrol 26: 425-438, 2015. 
57. Traykova-Brauch M, Schonig K, Greiner O, Miloud T, Jauch A, Bode M, Felsher DW, 
Glick AB, Kwiatkowski DJ, Bujard H, Horst J, von Knebel Doeberitz M, Niggli FK, Kriz W, 
Grone HJ, and Koesters R. An efficient and versatile system for acute and chronic modulation of renal 
tubular function in transgenic mice. Nat Med 14: 979-984, 2008. 
58. Vallon V, Schroth J, Lang F, Kuhl D, and Uchida S. Expression and phosphorylation of the 
Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol 
Renal Physiol 297: F704-712, 2009. 
59. van der Lubbe N, Moes AD, Rosenbaek LL, Schoep S, Meima ME, Danser AH, Fenton 
RA, Zietse R, and Hoorn EJ. K+-induced natriuresis is preserved during Na+ depletion and 
accompanied by inhibition of the Na+-Cl- cotransporter. Am J Physiol Renal Physiol 305: F1177-1188, 
2013. 
60. Vidal-Petiot E, Elvira-Matelot E, Mutig K, Soukaseum C, Baudrie V, Wu S, Cheval L, 
Huc E, Cambillau M, Bachmann S, Doucet A, Jeunemaitre X, and Hadchouel J. WNK1-related 
Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in 
the distal nephron. Proc Natl Acad Sci U S A 110: 14366-14371, 2013. 
61. Vitari AC, Deak M, Morrice NA, and Alessi DR. The WNK1 and WNK4 protein kinases that 
are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein 
kinases. Biochem J 391: 17-24, 2005. 
62. Wade JB, Fang L, Liu J, Li D, Yang CL, Subramanya AR, Maouyo D, Mason A, Ellison 
DH, and Welling PA. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl 
Acad Sci U S A 103: 8558-8563, 2006. 
63. Wagner CA, Loffing-Cueni D, Yan Q, Schulz N, Fakitsas P, Carrel M, Wang T, Verrey F, 
Geibel JP, Giebisch G, Hebert SC, and Loffing J. Mouse model of type II Bartter's syndrome. II. 
Altered expression of renal sodium- and water-transporting proteins. Am J Physiol Renal Physiol 294: 
F1373-1380, 2008. 
64. Welling PA. Regulation of renal potassium secretion: molecular mechanisms. Semin Nephrol 
33: 215-228, 2013. 
65. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel 
K, Loffing J, Kauselmann G, Bosl MR, Lang F, and Kuhl D. Impaired renal Na(+) retention in the 
sgk1-knockout mouse. J Clin Invest 110: 1263-1268, 2002. 
66. Yoo D, Kim BY, Campo C, Nance L, King A, Maouyo D, and Welling PA. Cell surface 
expression of the ROMK (Kir 1.1) channel is regulated by the aldosterone-induced kinase, SGK-1, and 
protein kinase A. J Biol Chem 278: 23066-23075, 2003. 
67. Youn JH, and McDonough AA. Recent advances in understanding integrative control of 
potassium homeostasis. Annu Rev Physiol 71: 381-401, 2009. 
68. Yue P, Lin DH, Pan CY, Leng Q, Giebisch G, Lifton RP, and Wang WH. Src family protein 
tyrosine kinase (PTK) modulates the effect of SGK1 and WNK4 on ROMK channels. Proc Natl Acad 
Sci U S A 106: 15061-15066, 2009. 
69. Yun CC, Palmada M, Embark HM, Fedorenko O, Feng Y, Henke G, Setiawan I, Boehmer 
C, Weinman EJ, Sandrasagra S, Korbmacher C, Cohen P, Pearce D, and Lang F. The Serum and 
Glucocorticoid-Inducible Kinase SGK1 and the Na(+)/H(+) Exchange Regulating Factor NHERF2 
Synergize to Stimulate the Renal Outer Medullary K(+) Channel ROMK1. J Am Soc Nephrol 13: 2823-
2830, 2002. 
70. Zhang C, Wang L, Zhang J, Su XT, Lin DH, Scholl UI, Giebisch G, Lifton RP, and Wang 
WH. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal 
convoluted tubule (DCT1). Proc Natl Acad Sci U S A 111: 11864-11869, 2014. 
 
24 
 
FIGURE LEGENDS 
Fig. 1. Sgk1 mRNA and SGK1 protein levels are decreased in the kidney, but not in the liver of 
Sgk1Pax8/LC1 mutant mice. A: PCR on genomic DNA extracted from total kidney and liver 
showing the WT and mutant (KO) Sgk1 bands after 12 days of doxycycline treatment. The 
intensity of the mutant band in the kidney is more pronounced than in the liver of the same 
animals. B:  qRT-PCR (TaqMan) analysis of Sgk1 mRNA in control and Sgk1Pax8/LC1 KO. A 
significant decreased of SGK1 mRNA level occurs in the kidney but not in the liver of the same 
animals, (n: 7 controls, 6 Sgk1Pax8/LC1). C: Western blot (WB) analysis of phosphorylated SGK1 
(p-T256) in protein lysates from total kidney (upper panel) and liver (lower panel) in control 
and Sgk1Pax8/LC1 KO. Actin was used as a loading control. D: Protein quantification of C 
showing an almost complete loss of pSGK1 in the kidney of mutant mice compared to control 
with no alteration of pSGK1 levels in the liver, (n: 6 controls, 7 Sgk1Pax8/LC1). *: p value < 0.05. 
 
Fig. 2. K+ excretion is defective in Sgk1Pax8/LC1 mice under HKD but not ND. A, B: Plasma K+ 
and Na+ in control (white columns) and Sgk1Pax8/LC1 (grey columns) mice showing significant 
hyperkalemia with a slight decrease in natremia in Sgk1Pax8/LC1 under HKD (n: 5 controls, 7 
Sgk1Pax8/LC1) but not under ND (n: 12 controls, 11 Sgk1Pax8/LC1). C: Plasma aldosterone is 
increased in Sgk1Pax8/LC1 versus control mice under ND (n: 12 controls, 13 Sgk1Pax8/LC1) and 
under HKD (n: 14 controls, 11 Sgk1Pax8/LC1). D,E: 24h urinary K+ and Na+ excretion indicating 
reduced K+ excretion in Sgk1Pax8/LC1 mutant animals with no significant difference in Na+ 
excretion (n: 12 controls,  13 Sgk1Pax8/LC1); *: α value < 0.05, **: α value < 0.01. F: Quantitative 
qRT-PCR (Taqman) on RNA isolated from kidneys of control or Sgk1Pax8/LC1 mice, kept under 
normal diet or 48h of HKD. 
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Fig. 3. Deregulation of ENaC in Sgk1Pax8/LC1 mice after 2 days of HKD. A: WB analysis of 
ENaC in control and Sgk1Pax8/LC1 mice showing a decrease in cleaved (Cl.) αENaC and in full-
length and cleaved γENaC, without alteration in βENaC. B: Protein quantification from A (n: 
6 controls, 7 Sgk1Pax8/LC1). C: Immunofluorescence (IF) images of ENaC in control and 
Sgk1Pax8/LC1mutant mice showing a decrease in the apical localization of αENaC (upper panel) 
and in the total expression of γENaC (third panel). βENaC exhibits similar pattern in both 
genotypes (second panel). *: p value < 0.05, **: p value < 0.01 
 
Fig. 4. Deregulation of the NEDD4-2/WNK1 pathway in Sgk1Pax8/LC1 mice after 2 days of HKD. 
(A) WB analysis of NEDD4-2 (N4-2) and WNK1 revealing a significant decrease in total and 
phosphorylated NEDD4-2 levels in Sgk1Pax8/LC1 mice. A slight (non-significant) alteration was 
observed in WNK1 total protein levels. (B) Protein quantification from (A), (n: 7 and 6 per 
group); *: p value < 0.05, **: p value < 0.01. (C) Immunofluorescence images of NEDD4-2 in 
control and Sgk1Pax8/LC1 mutant mice showing a decrease of total NEDD4-2 expression in the 
KO animal. (D) Co-staining of NCC (red) (upper panel) and WNK1 (green) (middle panel), a 
punctate pattern of WNK1 observed in the DCT of control animal disappears in Sgk1Pax8/LC1 
mice where WNK1 exhibit a diffused pattern. (E) Co-staining of AQP2 (red) and WNK1 
(green) showing the decrease in WNK1 expression in the CNT/CD of mutant compared to 
control animals.  
 
Fig. 5.  WNKs phosphorylation and likely activity is decreased in both DCT and CNT/CD of 
Sgk1Pax8/LC1 under HKD. A: Co-staining of AQP2 (green) and Pan-pWNK (red) showing 
reduced WNK phosphorylation in the CNT/CD of mutant compared to control animals. B: Co-
staining of NCC (green) and Pan-pWNK (red) showing decreased WNK phosphorylation in the 
DCT of Sgk1Pax8/LC1 compared to control animals. 
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Fig. 6. ROMK localization altered in Sgk1Pax8/LC1 mice under HKD. A,B: Validation of anti 
ROMK antibodies. A: Western blotting of ROMK from membrane enriched preparation of 
kidney extracts of control and Kcnj1 (ROMK) KO mice after 5 days of HKD. Fg: fully 
glycosylated, Pg partially glycosylated, Ng non glycosylated ROMK. B: Western blotting of 
ROMK of untransfected HEK293 cells (1) and cells transfected with ROMK (2). C: WB 
analysis of ROMK in control and Sgk1Pax8/LC1 mice after 2 days of HKD, Ng: non glycosylated, 
Pg: partially glycosylated, Fg: Fully glycosylated. D: Protein quantification from A revealing a 
slight increase in the fully glycosylated form of ROMK. E: Co-staining of ROMK (red) and 
ENaC (green) in the CNT/CD (D) F: ROMK (red) and NCC (green) in the DCT. ROMK is 
more enhanced at the apical membrane in the Sgk1Pax8/LC1 versus control mice in both ENaC 
and NCC expressing segments. Note that ROMK exhibits more pronounced apical localization 
in the DCT than in the CNT/CD.  
 
Fig. 7. Alteration in SPAK and NCC phosphorylation and cellular localization after 2 days of 
HKD. A: WB analysis of NCC in control and Sgk1Pax8/LC1 mice showing reduced NCC 
phosphorylation of several phosphorylation sites without alteration in NCC total expression in 
the Sgk1Pax8/LC1 mice. B: Protein quantification of A (n: 7 for both genotypes); *: p < 0.05, **: 
p < 0.01). C: Immunofluorescence images of total and T53 phosphorylated NCC in control and 
Sgk1Pax8/LC1 mice. The apical localization (upper panel) and the phosphorylation state of NCC 
(lower panel) are both altered in the Sgk1Pax8/LC1 animals. D: IF images of total SPAK showing 
a punctate pattern of SPAK in the control mice which becomes less pronounced in the 
Sgk1Pax8/LC1 animals. E: Co-staining of NCC (green) (upper panel) and T233 phosphorylated 
SPAK (red) (middle panel) showing decreased SPAK phosphorylation in the DCT of 
Sgk1Pax8/LC1 mice.  
Normal diet (0.3% K) high K diet (5% K)
WT (12) KO (13) WT (12) KO (13)
Body weight (g) 25.4 +/- 0.5 24.8 +/- 0.5 23.7 +/- 0.5 22.4 +/- 0.4
Food intake 24h/ body weight (g 24h/g of BW) 0.14 +/- 0.01 0.15 +/- 0.004 0.151 +/- 0.007 0.125 +/- 0.007
Water intake 24h/ body weight (ml 24h/g of BW) 0.18 +/- 0.01 0.21 +/- 0.01 0.34 +/- 0.02 * 0.33 +/- 0.02 *
Urine volume (ml 24h) 1.62 +/- 0.22 1.74 +/- 0.26 2.79 +/- 0.27 2.61 +/- 0.32
PO4 24/Creat 46.8 +/- 3.3 52.7 +/- 1.9 13.30 +/- 0.5 13.27 +/- 0.7
Mg 24/Creat 0.75 +/- 0.07 0.85 +/- 0.07 0.78 +/- 0.10 1.09 +/- 0.23
Ca 24 /Creat 1.59 +/- 0.5 2.38 +/- 0.68 1.10 +/- 0.16 1.01 +/- 0.13
Urea 24/Creat 530 +/- 84 436 +/- 77 307 +/- 13 319 +/- 20
Creat 24h/body weight (µmol 24h/g of BW) 162 +/- 29 135 +/- 11 304 +/- 14 264 +/- 18
Table 1: Metabolic parameters of control and SGK1Pax8/LC1 KO mice under normal diet and after 2 days of high K+ diet. No significant 
differences were observed in these parameters between control and mutant mice. (n=12 WT and 13 SGK1Pax8/LC1 KO mice in both diets).
Note that water intake 24h/body weight was significantly different between ND and HKD with no significant difference in urine volume 
between both diets which may result from the high variability due to the evaporation in metabolic cages. *= P < 0.05. 
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